Table I.
circ_0008450 expression | ||||
---|---|---|---|---|
Parameter | Patients, n | Low n=14 | High n=16 | P-value |
Age, years | 0.07 | |||
≤60 | 14 | 9 | 5 | |
>60 | 16 | 5 | 11 | |
Sex | 0.232 | |||
Female | 18 | 10 | 8 | |
Male | 12 | 4 | 8 | |
Tumor size, cm | 0.003a | |||
≤5 | 17 | 12 | 5 | |
>5 | 13 | 2 | 11 | |
TNM stage | 0.003a | |||
I–II | 15 | 11 | 4 | |
III | 15 | 3 | 12 | |
AFP, µg/l | 0.696 | |||
≤400 | 16 | 8 | 8 | |
>400 | 14 | 6 | 8 | |
Lymphatic metastasis | 0.0001a | |||
Negative | 12 | 11 | 1 | |
Positive | 18 | 3 | 15 | |
Vascular invasion | 0.961 | |||
Absent | 13 | 6 | 7 | |
Present | 17 | 8 | 9 | |
Distant metastasis | 0.0003a | |||
M0 | 15 | 12 | 3 | |
M1 | 15 | 2 | 13 |
P<0.05 as analyzed by χ2 tests. TNM, tumor, node and metastasis staging system; α-fetoprotein tumor marker. M0, HCC was not diffused. M1, HCC had spread to other parts of the body.